BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 26015073)

  • 1. Hydroxysafflor yellow A attenuate lipopolysaccharide-induced endothelium inflammatory injury.
    Jin M; Sun CY; Zang BX
    Chin J Integr Med; 2016 Jan; 22(1):36-41. PubMed ID: 26015073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxysafflor yellow A attenuates the expression of inflammatory cytokines in acute soft tissue injury.
    Dong F; Xue C; Wang Y; Peng Y; Zhang Y; Jin M; Zang B
    Sci Rep; 2017 Jan; 7():40584. PubMed ID: 28074914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Protective effect of hydroxysafflor yellow A on endothelial cell injury induced by lipopolysaccharide].
    Wang X; Zang B; Wu W; Tong J; Jin M
    Zhongguo Zhong Yao Za Zhi; 2011 Jun; 36(12):1650-3. PubMed ID: 22007554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxysafflor yellow a inhibits lipopolysaccharide-induced inflammatory signal transduction in human alveolar epithelial A549 cells.
    Song L; Zhu Y; Jin M; Zang B
    Fitoterapia; 2013 Jan; 84():107-14. PubMed ID: 23160090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aurintricarboxylic acid inhibits the nuclear factor-κB-dependent expression of intercellular cell adhesion molecule-1 and endothelial cell selectin on activated human endothelial cells.
    Kim JE; Lee S; Han KS; Kim HK
    Blood Coagul Fibrinolysis; 2011 Mar; 22(2):132-9. PubMed ID: 21245742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective Effect of Hydroxysafflor Yellow A on Inflammatory Injury in Chronic Obstructive Pulmonary Disease Rats.
    Jin M; Xue CJ; Wang Y; Dong F; Peng YY; Zhang YD; Zang BX; Tan L
    Chin J Integr Med; 2019 Oct; 25(10):750-756. PubMed ID: 30588579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan oligosaccharides downregulate the expression of E-selectin and ICAM-1 induced by LPS in endothelial cells by inhibiting MAP kinase signaling.
    Li Y; Xu Q; Wei P; Cheng L; Peng Q; Li S; Yin H; Du Y
    Int J Mol Med; 2014 Feb; 33(2):392-400. PubMed ID: 24336934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxysafflor Yellow A of Carthamus Tinctorius L., Represses the Malignant Development of Esophageal Cancer Cells via Regulating NF-κB Signaling Pathway.
    Chen X; Wang Y; Zhang L; Gao Y
    Cell Biochem Biophys; 2020 Dec; 78(4):511-520. PubMed ID: 32705535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leonurine attenuates lipopolysaccharide-induced inflammatory responses in human endothelial cells: involvement of reactive oxygen species and NF-κB pathways.
    Liu XH; Pan LL; Yang HB; Gong QH; Zhu YZ
    Eur J Pharmacol; 2012 Apr; 680(1-3):108-14. PubMed ID: 22305882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibitory effect of hydroxysafflor yellow A against PMN activation induced by LPS].
    Wu W; Jin M; Tong J; Wang XF; Zang BX
    Yao Xue Xue Bao; 2011 Feb; 46(2):153-7. PubMed ID: 21542285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ability of hydroxysafflor yellow a to attenuate lipopolysaccharide-induced pulmonary inflammatory injury in mice.
    Sun CY; Pei CQ; Zang BX; Wang L; Jin M
    Phytother Res; 2010 Dec; 24(12):1788-95. PubMed ID: 20564507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxysafflor Yellow A Attenuates Lipopolysaccharide-Induced Neurotoxicity and Neuroinflammation in Primary Mesencephalic Cultures.
    Wang T; Ding YX; He J; Ma CJ; Zhao Y; Wang ZH; Han B
    Molecules; 2018 May; 23(5):. PubMed ID: 29783643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unfractionated heparin inhibits lipopolysaccharide-induced inflammatory response through blocking p38 MAPK and NF-κB activation on endothelial cell.
    Li X; Zheng Z; Li X; Ma X
    Cytokine; 2012 Oct; 60(1):114-21. PubMed ID: 22763042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipopolysaccharide and sphingosine-1-phosphate cooperate to induce inflammatory molecules and leukocyte adhesion in endothelial cells.
    Fernández-Pisonero I; Dueñas AI; Barreiro O; Montero O; Sánchez-Madrid F; García-Rodríguez C
    J Immunol; 2012 Dec; 189(11):5402-10. PubMed ID: 23089395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxysafflor yellow A inhibits angiogenesis of hepatocellular carcinoma via blocking ERK/MAPK and NF-κB signaling pathway in H22 tumor-bearing mice.
    Yang F; Li J; Zhu J; Wang D; Chen S; Bai X
    Eur J Pharmacol; 2015 May; 754():105-14. PubMed ID: 25720342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxysafflor Yellow A Alleviates Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Mice.
    Zhang Y; Song L; Pan R; Gao J; Zang BX; Jin M
    Biol Pharm Bull; 2017; 40(2):135-144. PubMed ID: 28154251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibitory action of hydroxysafflor yellow A on inflammatory signal transduction pathway related factors in rats with cerebral cortex ischemia].
    Chen TT; Du YJ; Liu XL; Zhu HB
    Yao Xue Xue Bao; 2008 Jun; 43(6):570-5. PubMed ID: 18822957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxysafflor yellow A ameliorates lipopolysaccharide-induced acute lung injury in mice via modulating toll-like receptor 4 signaling pathways.
    Liu YL; Liu YJ; Liu Y; Li XS; Liu SH; Pan YG; Zhang J; Liu Q; Hao YY
    Int Immunopharmacol; 2014 Dec; 23(2):649-57. PubMed ID: 25466274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of hydroxysafflor yellow A on bleomycin- induced pulmonary inflammation and fibrosis in rats.
    Jin M; Wang L; Wu Y; Zang BX; Tan L
    Chin J Integr Med; 2018 Jan; 24(1):32-39. PubMed ID: 29294256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxysafflor yellow A enhances survival of vascular endothelial cells under hypoxia via upregulation of the HIF-1 alpha-VEGF pathway and regulation of Bcl-2/Bax.
    Ji DB; Zhu MC; Zhu B; Zhu YZ; Li CL; Ye J; Zhu HB
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):191-202. PubMed ID: 18670359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.